Efficacy and safety of a new food supplement in the treatment of functional dyspepsia: an open study
Current treatments for functional dyspepsia (FD) are based on neutralizing gastric acidity, which favors food digestion and sterilization. Hence, the risk of negative consequences. This study was aimed at assessing the ability of a food supplement, based on hydrolyzed collagen and tricalcium phosphate, to ameliorate FD symptoms.
Methods: 22 patients were recruited according to the Rome IV criteria. Subjects were neither pregnant nor breastfeeding. They had a normal upper endoscopy prior to enrolment, with no current of antacid, antisecretory, prokinetic, antidepressant and anxiolytic use. Individuals with kidney, biliary and pancreatic diseases were excluded.
Gastrointestinal symptoms were measured by the Gastrointestinal Rating Scale (GSRS) questionnaire before and after 28-days of therapy. Adverse effects were monitored during and after the treatment.
Results: Compared to baseline, a significant total score reduction (p = 0.0062) was recorded. The main symptoms that decreased were abdominal pain and eructation (-0.9 ± 1.6 p-value 0.0161). The nutritional supplement was found to be safe and well tolerated.
Conclusion: Dyspeptic symptoms were reduced in all patients, representing the effectiveness and safety of the nutritional supplement.